UK Companies House feature
THE TRINITY CHALLENGE
Profile
- Company number
- 12756885
- Status
- Active
- Incorporation
- 2020-07-20
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Moore Kingston Smith LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“It is the Board's view that the reserves of the Trinity Challenge are such that it will continue to meet its financial obligations to pay prize winners' grants and innovation support costs in full for the first two challenges. Additionally, the Trustees will not make expenditure commitments in excess of committed income for the third public Challenge. As such, these accounts and the accompanying report have been created on a going concern basis.”
Significant events
- “Our charity was set up during COVID-19 - a pandemic that so painfully exposed the consequences of inadequate data systems and unpreparedness.”
- “In 2024, we focused on Antimicrobial Resistance (AMR).”
- “Our second global innovation competition, the Trinity Challenge on Antimicrobial Resistance, drew an extraordinary 285 applications from 57 countries.”
- “We have launched a series of engagements with young people, to raise awareness and galvanise action on AMR. Through our inaugural Youth Summit and Competition, we reached over 400 young people.”
- “A unique collaboration with the Stanford Deliberative Polling Lab engaged 2,500 individuals across six middle-income countries to better understand public attitudes on AMR.”
- “The Trinity Challenge on Antimicrobial Resistance concluded in 2024. The winning projects launched in November and will continue to 2026/7.”
- “In 2024, VaccineLedger achieved a groundbreaking milestone with its nationwide deployment in Bangladesh. This implementation is estimated to digitally track 100 million vaccine doses annually.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 1 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DAVIES, Sally | Director | 2020-07-20 | Nov 1949 | British |
| DAVIS, Stephen Brown | Director | 2020-08-24 | Aug 1957 | American |
| SECHER, David Stanley, Dr | Director | 2022-11-30 | Jul 1948 | British |
| SPENSLEY, Sally Sharon Bird | Director | 2020-09-27 | Jul 1958 | British |
| STANLEY, Ian George | Director | 2022-01-26 | Apr 1957 | British |
Show 1 resigned officer
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LAMPARD, Kathryn Felice | Director | 2020-08-24 | 2021-11-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Miss Kathryn Felice Lampard | Individual | Voting 25–50% | 2020-08-24 | Ceased 2020-09-27 |
| Mr Stephen Brown Davis | Individual | Voting 25–50% | 2020-08-24 | Ceased 2020-09-27 |
| Sally Davies | Individual | Voting 25–50% | 2020-07-20 | Ceased 2020-09-27 |
Filing timeline
Last 20 of 28 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-09-23 | AA | accounts | accounts with accounts type full |
| 2025-07-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-26 | AA | accounts | accounts with accounts type full |
| 2024-07-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-02 | AA | accounts | accounts with accounts type full |
| 2023-07-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-02-02 | AP01 | officers | appoint person director company with name date |
| 2022-08-02 | CH01 | officers | change person director company with change date |
| 2022-08-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-07-22 | AA | accounts | accounts with accounts type full |
| 2022-01-31 | AP01 | officers | appoint person director company with name date |
| 2021-12-01 | TM01 | officers | termination director company with name termination date |
| 2021-07-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-07-06 | AA01 | accounts | change account reference date company current extended |
| 2020-09-29 | PSC08 | persons-with-significant-control | notification of a person with significant control statement |
| 2020-09-29 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2020-09-29 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2020-09-29 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2020-09-29 | AP01 | officers | appoint person director company with name date |
| 2020-09-23 | CH01 | officers | change person director company with change date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.